VERAX BIOMEDICAL INC — Form D/A

VERAX BIOMEDICAL INC of WORCESTER, MA, a company, filed a Form D amendment with the SEC on 2016-06-27. The offering totals $24.5M, of which $12.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
JAMES E KOZIARZDirectorMARLBOROUGH, MA
JOE R SANDERSDirectorMARLBOROUGH, MA
NANCY A HORNBAKERExecutive OfficerMARLBOROUGH, MA
R. SCOTT MCKENZIEExecutive OfficerWORCESTER, MA
PAUL REMO RAGUSAExecutive OfficerMARLBOROUGH, MA
JOE R SANDERSExecutive OfficerMARLBOROUGH, MA
YLI REMO VALLEJOExecutive OfficerMARLBOROUGH, MA
Robert ZieserlDirectorWORCESTER, MA
Marc GoldbergDirectorWORCESTER, MA
Buzz BensonDirectorWORCESTER, MA
James LousararianDirectorWORCESTER, MA
James LousararianExecutive OfficerWORCESTER, MA
Robert FlanaganDirectorCresskill, NJ
Paul RagusaExecutive OfficerMarlborough, MA
Joe SandersDirectorMarlborough, MA
Joe SandersExecutive OfficerMarlborough, MA
JOE DEL GUERCIODirectorWORCESTER, MA
JAMES KOZIARZDirectorWORCESTER, MA
R. SCOTT MCKENZIE, SR.Executive OfficerMARLBOROUGH, MA
GREGORY SCOTT LAWRENCEExecutive OfficerMARLBOROUGH, MA
PAUL SCOTT RAGUSAExecutive OfficerMARLBOROUGH, MA
GREG SCOTT LAWRENCEExecutive OfficerWORCESTER, MA
Marc E GoldbergDirectorStoughton, MA
JEFFREY A HALLExecutive OfficerWORCESTER, MA
NANCY A. HORNBAKERExecutive OfficerWORCESTER, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2019-09-19D$10.5M$2.5M
2017-11-13D$24.1M$11.4M
2016-03-02D$12.6M$12.6M
2015-01-21D$4.0M$4.0M
2013-10-15D/A$11.8M$8.5M
2013-07-31D$11.8M$6.8M
2012-10-25D/A$5.0M$3.3M
2012-08-14D$5.0M$2.8M
2011-03-22D$1.3M$1.3M
2009-04-15D$10.0M$2.1M

More